Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981;100(1):113-6.
doi: 10.1007/BF00405909.

Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma

Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma

M E Heim et al. J Cancer Res Clin Oncol. 1981.

Abstract

Ten patients with advanced renal carcinoma were treated by ifosfamide (50-60 mg/kd/day x 5 days). The treatment was repeated every 4 weeks and continued until progression appeared. Two patients came into partial remission, two had subjective improvement, and six did not respond. Seven patients developed acute psychopathological symptoms during the first ifosfamide-cycle. Five patients had visual and paranoid hallucinations, four patients were completely confused. Follow-up for up to 10 weeks showed a persisting organic brain syndrome in five patients.

PubMed Disclaimer

References

    1. Allen LM, Creaven PJ (1975) Pharmacokinetics of ifosfamide. Clin Pharmacol Ther 17:492–498 - PubMed
    1. Creaven PJ, Allen LM, Alford DA, Cohen MH (1974) Clinical pharmacology of isophosphamide. Clin Pharmacol Ther 16:77–86 - PubMed
    1. Hartwich G, Neidhardt B, Lutz H (1978) Klinische Erfahrungen mit Holoxan im Rahmen einer sequentiellen Kombinationstherapie. Med Klin 73:1247–1252 - PubMed
    1. Hoefer-Janker H, Scheef W, Günther U, Hüls W (1975) Erfahrungen mit der fraktionierten Ifosfamid-Stoßtherapie bei generalisierten malignen tumoren. Med Welt 26:972–979 - PubMed
    1. Ritter S, Schröder HJ (1977) Klinische Erfahrungen mit dem Zytostatikum Ifosfamid. Med Welt 28:1395–1400 - PubMed

LinkOut - more resources